- Home
- MCRB vs RVPHW Comparison
MCRB vs RVPHW Comparison
Compare MCRB & RVPHW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MCRB
- RVPHW
- Stock Information
- Founded
- MCRB 2010
- RVPHW N/A
- Country
- MCRB United States
- RVPHW United States
- Employees
- MCRB N/A
- RVPHW 15
- Industry
- MCRB Biotechnology: Pharmaceutical Preparations
- RVPHW Biotechnology: Pharmaceutical Preparations
- Sector
- MCRB Health Care
- RVPHW Health Care
- Exchange
- MCRB Nasdaq
- RVPHW Nasdaq
- Market Cap
- MCRB N/A
- RVPHW N/A
- IPO Year
- MCRB 2015
- RVPHW 2018
- Fundamental
- Price
- MCRB $0.81
- RVPHW $0.17
- Analyst Decision
- MCRB Buy
- RVPHW
- Analyst Count
- MCRB 4
- RVPHW 0
- Target Price
- MCRB $5.63
- RVPHW N/A
- AVG Volume (30 Days)
- MCRB 3.1M
- RVPHW N/A
- Earning Date
- MCRB 11-13-2024
- RVPHW N/A
- Dividend Yield
- MCRB N/A
- RVPHW N/A
- EPS Growth
- MCRB N/A
- RVPHW N/A
- EPS
- MCRB N/A
- RVPHW N/A
- Revenue
- MCRB $126,325,000.00
- RVPHW N/A
- Revenue This Year
- MCRB N/A
- RVPHW N/A
- Revenue Next Year
- MCRB $215.76
- RVPHW N/A
- P/E Ratio
- MCRB N/A
- RVPHW N/A
- Revenue Growth
- MCRB N/A
- RVPHW N/A
- 52 Week Low
- MCRB $0.54
- RVPHW N/A
- 52 Week High
- MCRB $2.05
- RVPHW N/A
- Technical
- Relative Strength Index (RSI)
- MCRB 57.18
- RVPHW N/A
- Support Level
- MCRB $0.54
- RVPHW N/A
- Resistance Level
- MCRB $0.76
- RVPHW N/A
- Average True Range (ATR)
- MCRB 0.08
- RVPHW 0.00
- MACD
- MCRB 0.01
- RVPHW 0.00
- Stochastic Oscillator
- MCRB 79.45
- RVPHW 0.00
About RVPHW Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and its other drug candidate is RP1208.